Finding biomarkers for autoimmune responses in Alzheimer's disease.
Discovery and validation of biomarkers of autoimmunity in Alzheimer's Disease.
This study is looking for special markers in the fluid around your brain that can help tell Alzheimer's apart from other brain diseases and track how it changes over time, which could lead to better ways to diagnose and manage the condition.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sinai Health System NIH-funded |
| Lab location | 1 site (Toronto, Canada) |
| Project ID | NIH-10990984 on NIH RePORTER |
What this research studies
This research aims to identify specific biomarkers that can help differentiate Alzheimer's disease from other neurodegenerative disorders and track its progression. By analyzing cerebrospinal fluid, the team will look for autoantibodies and immune complexes that may contribute to the disease. Using advanced mass spectrometry techniques, they will discover these biomarkers and develop targeted assays for further testing in both cerebrospinal fluid and serum. This approach could lead to more accurate diagnoses and better management of Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those exhibiting symptoms of neurodegenerative disorders.
Not a fit: Patients with neurodegenerative disorders other than Alzheimer's disease may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and monitoring methods for Alzheimer's disease, enhancing patient care.
How similar studies have performed: Previous research has shown promise in identifying biomarkers for other neurodegenerative diseases, suggesting potential success for this novel approach.
Where this research is happening
Toronto, Canada
- Sinai Health System — Toronto, Canada (Active)
Researchers
- Principal investigator: Diamandis, Eleftherios P — Sinai Health System
- Study coordinator: Diamandis, Eleftherios P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.